Friday, November 03, 2017 10:15 PM ET
Avexis (AVXS) Insider Makes Significant Share Sale
There was a significant sale of shares of Avexis by an insider today, as revealed in a form 4 document filed with the SEC. One insider — Dr Brian K Kaspar, 10% Owner, Director and Officer — disposed of 15,000 shares in the company having a market value of approximately $1,518,416. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 15,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 30,000 shares and have averaged 15,000 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Avexis is above its 269-company peer group average. The Bio Therapeutic Drugs peer group saw 326 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Avexis insiders is lower than its peers. Within the peer group there were 25,999,828 shares purchased and 12,376,431 shares sold with company insiders having bought 66,456 shares on average over this time period.
The data used in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.